Haloperidol Drug Interactions
396Total Interactions
122Severe
22Moderate
0Mild
| Drug | Severity | Summary |
|---|---|---|
| Amifampridine | SEVERE | Both Haloperidol and Amifampridine prolong the QT interval. Most manufacturers advise avoiding th... |
| Aminophylline | SEVERE | Aminophylline is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Amiodarone | SEVERE | Both Haloperidol and Amiodarone prolong the QT interval. Most manufacturers advise avoiding the u... |
| Amisulpride | SEVERE | Both Haloperidol and Amisulpride prolong the QT interval. Most manufacturers advise avoiding the ... |
| Amphotericin B | SEVERE | Amphotericin B is predicted to cause hypokalaemia (potentially increasing the risk of torsade de ... |
| Anagrelide | SEVERE | Both Haloperidol and Anagrelide prolong the QT interval. Most manufacturers advise avoiding the u... |
| Apalutamide | SEVERE | Both Haloperidol and Apalutamide prolong the QT interval. Most manufacturers advise avoiding the ... |
| Apomorphine | SEVERE | Both Haloperidol and Apomorphine prolong the QT interval. Most manufacturers advise avoiding the ... |
| Aripiprazole | SEVERE | Both Haloperidol and Aripiprazole prolong the QT interval. Most manufacturers advise avoiding the... |
| Arsenic trioxide | SEVERE | Both Haloperidol and Arsenic trioxide prolong the QT interval. Most manufacturers advise avoiding... |
| Artemether | SEVERE | Both Haloperidol and Artemether prolong the QT interval. Most manufacturers advise avoiding the u... |
| Artenimol | SEVERE | Both Haloperidol and Artenimol prolong the QT interval. Most manufacturers advise avoiding the us... |
| Beclometasone | SEVERE | Beclometasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Bedaquiline | SEVERE | Both Haloperidol and Bedaquiline prolong the QT interval. Most manufacturers advise avoiding the ... |
| Bendroflumethiazide | SEVERE | Bendroflumethiazide is predicted to cause hypokalaemia (potentially increasing the risk of torsad... |
| Betamethasone | SEVERE | Betamethasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Bosutinib | SEVERE | Both Haloperidol and Bosutinib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Budesonide | SEVERE | Budesonide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Bumetanide | SEVERE | Bumetanide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Cabozantinib | SEVERE | Both Haloperidol and Cabozantinib prolong the QT interval. Most manufacturers advise avoiding the... |
| Ceritinib | SEVERE | Both Haloperidol and Ceritinib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Chlorothiazide | SEVERE | Chlorothiazide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de ... |
| Chlorpromazine | SEVERE | Both Haloperidol and Chlorpromazine prolong the QT interval. Most manufacturers advise avoiding t... |
| Chlortalidone | SEVERE | Chlortalidone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Citalopram | SEVERE | Both Haloperidol and Citalopram prolong the QT interval. Most manufacturers advise avoiding the u... |
| Clomipramine | SEVERE | Both Haloperidol and Clomipramine prolong the QT interval. Most manufacturers advise avoiding the... |
| Clozapine | SEVERE | Clozapine can cause constipation, as can Haloperidol ; concurrent use might increase the risk of ... |
| Crizotinib | SEVERE | Both Haloperidol and Crizotinib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Dasatinib | SEVERE | Both Haloperidol and Dasatinib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Deflazacort | SEVERE | Deflazacort is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poi... |
| Delamanid | SEVERE | Both Haloperidol and Delamanid prolong the QT interval. Most manufacturers advise avoiding the us... |
| Desflurane | SEVERE | Both Haloperidol and Desflurane prolong the QT interval. Most manufacturers advise avoiding the u... |
| Dexamethasone | SEVERE | Dexamethasone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Disopyramide | SEVERE | Both Haloperidol and Disopyramide prolong the QT interval. Most manufacturers advise avoiding the... |
| Domperidone | SEVERE | Domperidone increases the risk of QT-prolongation when given with Haloperidol. Manufacturer advis... |
| Dronedarone | SEVERE | Both Haloperidol and Dronedarone prolong the QT interval. Most manufacturers advise avoiding the ... |
| Droperidol | SEVERE | Both Haloperidol and Droperidol prolong the QT interval. Most manufacturers advise avoiding the u... |
| Efavirenz | SEVERE | Both Haloperidol and Efavirenz prolong the QT interval. Most manufacturers advise avoiding the us... |
| Encorafenib | SEVERE | Both Haloperidol and Encorafenib prolong the QT interval. Most manufacturers advise avoiding the ... |
| Entrectinib | SEVERE | Both Haloperidol and Entrectinib prolong the QT interval. Most manufacturers advise avoiding the ... |
| Eribulin | SEVERE | Both Haloperidol and Eribulin prolong the QT interval. Most manufacturers advise avoiding the use... |
| Erythromycin | SEVERE | Both Haloperidol and Erythromycin prolong the QT interval. Most manufacturers advise avoiding the... |
| Escitalopram | SEVERE | Both Haloperidol and Escitalopram prolong the QT interval. Most manufacturers advise avoiding the... |
| Etrasimod | SEVERE | Etrasimod might increase the risk of QT-prolongation when given with Haloperidol. Manufacturer ad... |
| Fingolimod | SEVERE | Fingolimod might increase the risk of QT-prolongation when given with Haloperidol. Manufacturer a... |
| Fluconazole | SEVERE | Both Haloperidol and Fluconazole prolong the QT interval. Most manufacturers advise avoiding the ... |
| Fludrocortisone | SEVERE | Fludrocortisone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de... |
| Formoterol | SEVERE | Formoterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Foslevodopa | SEVERE | Haloperidol opposes the effects of the active metabolite of Foslevodopa. Manufacturer advises mon... |
| Furosemide | SEVERE | Furosemide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Glasdegib | SEVERE | Both Haloperidol and Glasdegib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Granisetron | SEVERE | Granisetron is predicted to increase the risk of QT-prolongation when given with Haloperidol. Man... |
| Hydrochlorothiazide | SEVERE | Hydrochlorothiazide is predicted to cause hypokalaemia (potentially increasing the risk of torsad... |
| Hydrocortisone | SEVERE | Hydrocortisone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de ... |
| Hydroflumethiazide | SEVERE | Hydroflumethiazide is predicted to cause hypokalaemia (potentially increasing the risk of torsade... |
| Hydroxychloroquine | SEVERE | Both Haloperidol and Hydroxychloroquine prolong the QT interval. Most manufacturers advise avoidi... |
| Hydroxyzine | SEVERE | Both Haloperidol and Hydroxyzine prolong the QT interval. Most manufacturers advise avoiding the ... |
| Indacaterol | SEVERE | Indacaterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poi... |
| Indapamide | SEVERE | Indapamide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Inotuzumab ozogamicin | SEVERE | Both Haloperidol and Inotuzumab ozogamicin prolong the QT interval. Most manufacturers advise avo... |
| Isoflurane | SEVERE | Both Haloperidol and Isoflurane prolong the QT interval. Most manufacturers advise avoiding the u... |
| Isoprenaline | SEVERE | Isoprenaline is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Ivabradine | SEVERE | Ivabradine is predicted to increase the risk of torsade de pointes when given with Haloperidol. M... |
| Ivosidenib | SEVERE | Both Haloperidol and Ivosidenib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Lapatinib | SEVERE | Both Haloperidol and Lapatinib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Lenvatinib | SEVERE | Both Haloperidol and Lenvatinib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Levodopa | SEVERE | Haloperidol decreases the effects of Levodopa. Manufacturer advises caution and monitor worsening... |
| Levomepromazine | SEVERE | Both Haloperidol and Levomepromazine prolong the QT interval. Most manufacturers advise avoiding ... |
| Mefloquine | SEVERE | Mefloquine is predicted to increase the risk of QT-prolongation when given with Haloperidol. Manu... |
| Methadone | SEVERE | Both Haloperidol and Methadone prolong the QT interval. Most manufacturers advise avoiding the us... |
| Methylprednisolone | SEVERE | Methylprednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade... |
| Metolazone | SEVERE | Metolazone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Mizolastine | SEVERE | Mizolastine is predicted to increase the risk of QT-prolongation when given with Haloperidol. Man... |
| Moxifloxacin | SEVERE | Both Haloperidol and Moxifloxacin prolong the QT interval. Most manufacturers advise avoiding the... |
| Nilotinib | SEVERE | Both Haloperidol and Nilotinib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Nirmatrelvir | SEVERE | Nirmatrelvir boosted with ritonavir is predicted to increase the concentration of Haloperidol. Ma... |
| Olodaterol | SEVERE | Olodaterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Ondansetron | SEVERE | Both Haloperidol and Ondansetron prolong the QT interval. Most manufacturers advise avoiding the ... |
| Osilodrostat | SEVERE | Both Haloperidol and Osilodrostat prolong the QT interval. Most manufacturers advise avoiding the... |
| Osimertinib | SEVERE | Both Haloperidol and Osimertinib prolong the QT interval. Most manufacturers advise avoiding the ... |
| Ozanimod | SEVERE | Ozanimod might increase the risk of QT-prolongation when given with Haloperidol. Manufacturer adv... |
| Paliperidone | SEVERE | Both Haloperidol and Paliperidone prolong the QT interval. Most manufacturers advise avoiding the... |
| Palonosetron | SEVERE | Palonosetron is predicted to increase the risk of QT-prolongation when given with Haloperidol. Ma... |
| Panobinostat | SEVERE | Both Haloperidol and Panobinostat prolong the QT interval. Most manufacturers advise avoiding the... |
| Pasireotide | SEVERE | Both Haloperidol and Pasireotide prolong the QT interval. Most manufacturers advise avoiding the ... |
| Pazopanib | SEVERE | Both Haloperidol and Pazopanib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Pentamidine | SEVERE | Pentamidine (intravenous or intramuscular) might increase the risk of QT-prolongation when given ... |
| Pimozide | SEVERE | Both Haloperidol and Pimozide prolong the QT interval. Most manufacturers advise avoiding the use... |
| Ponesimod | SEVERE | Ponesimod might increase the risk of QT-prolongation when given with Haloperidol. Manufacturer ad... |
| Prednisolone | SEVERE | Prednisolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Promethazine | SEVERE | Both Haloperidol and Promethazine prolong the QT interval. Most manufacturers advise avoiding the... |
| Quinine | SEVERE | Both Haloperidol and Quinine prolong the QT interval. Most manufacturers advise avoiding the use ... |
| Quizartinib | SEVERE | Both Haloperidol and Quizartinib prolong the QT interval. Most manufacturers advise avoiding the ... |
| Ranolazine | SEVERE | Both Haloperidol and Ranolazine prolong the QT interval. Most manufacturers advise avoiding the u... |
| Ribociclib | SEVERE | Both Haloperidol and Ribociclib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Ritonavir | SEVERE | Ritonavir is predicted to increase the exposure to Haloperidol. Manufacturer advises monitor adve... |
| Salbutamol | SEVERE | Salbutamol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Salmeterol | SEVERE | Salmeterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Selpercatinib | SEVERE | Both Haloperidol and Selpercatinib prolong the QT interval. Most manufacturers advise avoiding th... |
| Sevoflurane | SEVERE | Both Haloperidol and Sevoflurane prolong the QT interval. Most manufacturers advise avoiding the ... |
| Siponimod | SEVERE | Siponimod might increase the risk of QT-prolongation when given with Haloperidol. Manufacturer ad... |
| Sorafenib | SEVERE | Both Haloperidol and Sorafenib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Sotalol | SEVERE | Both Haloperidol and Sotalol prolong the QT interval. Most manufacturers advise avoiding the use ... |
| Sunitinib | SEVERE | Both Haloperidol and Sunitinib prolong the QT interval. Most manufacturers advise avoiding the us... |
| Terbutaline | SEVERE | Terbutaline is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poi... |
| Tetrabenazine | SEVERE | Both Haloperidol and Tetrabenazine prolong the QT interval. Most manufacturers advise avoiding th... |
| Theophylline | SEVERE | Theophylline is predicted to cause hypokalaemia (potentially increasing the risk of torsade de po... |
| Tolterodine | SEVERE | Both Haloperidol and Tolterodine prolong the QT interval. Most manufacturers advise avoiding the ... |
| Torasemide | SEVERE | Torasemide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Toremifene | SEVERE | Both Haloperidol and Toremifene prolong the QT interval. Most manufacturers advise avoiding the u... |
| Triamcinolone | SEVERE | Triamcinolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de p... |
| Vamorolone | SEVERE | Vamorolone is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Vandetanib | SEVERE | Both Haloperidol and Vandetanib prolong the QT interval. Most manufacturers advise avoiding the u... |
| Vardenafil | SEVERE | Both Haloperidol and Vardenafil prolong the QT interval. Most manufacturers advise avoiding the u... |
| Vemurafenib | SEVERE | Both Haloperidol and Vemurafenib prolong the QT interval. Most manufacturers advise avoiding the ... |
| Venlafaxine | SEVERE | Venlafaxine slightly increases the exposure to Haloperidol. Manufacturer makes no recommendation. |
| Vernakalant | SEVERE | Both Haloperidol and Vernakalant prolong the QT interval. Most manufacturers advise avoiding the ... |
| Vilanterol | SEVERE | Vilanterol is predicted to cause hypokalaemia (potentially increasing the risk of torsade de poin... |
| Voclosporin | SEVERE | Both Haloperidol and Voclosporin prolong the QT interval. Most manufacturers advise avoiding the ... |
| Voriconazole | SEVERE | Both Haloperidol and Voriconazole prolong the QT interval. Most manufacturers advise avoiding the... |
| Xipamide | SEVERE | Xipamide is predicted to cause hypokalaemia (potentially increasing the risk of torsade de pointe... |
| Zonisamide | SEVERE | Haloperidol potentially increases the risk of overheating and dehydration when given with Zonisam... |
| Amantadine | MODERATE | Haloperidol is predicted to decrease the effects of Amantadine. Manufacturer advises avoid. |
| Bromocriptine | MODERATE | Haloperidol is predicted to decrease the effects of Bromocriptine. Manufacturer advises avoid. |
| Cabergoline | MODERATE | Haloperidol is predicted to decrease the effects of Cabergoline. Manufacturer advises avoid. |
| Carbamazepine | MODERATE | Carbamazepine decreases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Enzalutamide | MODERATE | Enzalutamide decreases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Fluoxetine | MODERATE | Fluoxetine increases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Fluvoxamine | MODERATE | Fluvoxamine increases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Fosphenytoin | MODERATE | Fosphenytoin decreases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Glycerol phenylbutyrate | MODERATE | Haloperidol potentially opposes the effects of Glycerol phenylbutyrate. Manufacturer advises moni... |
| Itraconazole | MODERATE | Itraconazole increases the concentration of Haloperidol. Manufacturer advises caution. |
| Lumacaftor | MODERATE | Lumacaftor decreases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Mitotane | MODERATE | Mitotane decreases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Phenobarbital | MODERATE | Phenobarbital decreases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Phenytoin | MODERATE | Phenytoin decreases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Pramipexole | MODERATE | Haloperidol is predicted to decrease the effects of Pramipexole. Manufacturer advises avoid. |
| Primidone | MODERATE | Primidone decreases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Quinagolide | MODERATE | Haloperidol is predicted to decrease the effects of Quinagolide. Manufacturer advises avoid. |
| Rifampicin | MODERATE | Rifampicin decreases the concentration of Haloperidol. Manufacturer advises adjust dose. |
| Ropinirole | MODERATE | Haloperidol is predicted to decrease the effects of Ropinirole. Manufacturer advises avoid. |
| Rotigotine | MODERATE | Haloperidol is predicted to decrease the effects of Rotigotine. Manufacturer advises avoid. |
| Sodium phenylbutyrate | MODERATE | Haloperidol potentially decreases the effects of Sodium phenylbutyrate. Manufacturer advises moni... |
| Vasopressin | MODERATE | Haloperidol might enhance the antidiuretic and hypertensive effects of Vasopressin. Manufacturer ... |
| Acebutolol | LOW | Both Haloperidol and Acebutolol can increase the risk of hypotension. |
| Aceclofenac | LOW | Both Haloperidol and Aceclofenac can increase the risk of hyponatraemia. |
| Aclidinium | LOW | Both Haloperidol and Aclidinium can cause antimuscarinic effects. |
| Agomelatine | LOW | Both Haloperidol and Agomelatine have effects on the CNS and can cause sedation, which might affe... |
| Alcohol | LOW | Both Haloperidol and Alcohol can increase the risk of hypotension. |
| Alfentanil | LOW | Both Haloperidol and Alfentanil have effects on the CNS and can cause sedation, which might affec... |
| Alfuzosin | LOW | Both Haloperidol and Alfuzosin can increase the risk of hypotension. |
| Alimemazine | LOW | Both Haloperidol and Alimemazine have effects on the CNS and can cause sedation, which might affe... |
| Aliskiren | LOW | Both Haloperidol and Aliskiren can increase the risk of hypotension. |
| Alprazolam | LOW | Both Haloperidol and Alprazolam have effects on the CNS and can cause sedation, which might affec... |
| Alprostadil | LOW | Both Haloperidol and Alprostadil can increase the risk of hypotension. |
| Amiloride | LOW | Both Haloperidol and Amiloride can increase the risk of hyponatraemia. |
| Amitriptyline | LOW | Both Haloperidol and Amitriptyline can increase the risk of hyponatraemia. |
| Amlodipine | LOW | Both Haloperidol and Amlodipine can increase the risk of hypotension. |
| Apraclonidine | LOW | Both Haloperidol and Apraclonidine can increase the risk of hypotension. |
| Asenapine | LOW | Both Haloperidol and Asenapine can increase the risk of hyponatraemia. |
| Atenolol | LOW | Both Haloperidol and Atenolol can increase the risk of hypotension. |
| Atropine | LOW | Both Haloperidol and Atropine can cause antimuscarinic effects. |
| Avanafil | LOW | Both Haloperidol and Avanafil can increase the risk of hypotension. |
| Azilsartan | LOW | Both Haloperidol and Azilsartan can increase the risk of hypotension. |
| Baclofen | LOW | Both Haloperidol and Baclofen can increase the risk of hypotension. |
| Benperidol | LOW | Both Haloperidol and Benperidol can increase the risk of hyponatraemia. |
| Betaxolol | LOW | Both Haloperidol and Betaxolol can increase the risk of hypotension. |
| Bisoprolol | LOW | Both Haloperidol and Bisoprolol can increase the risk of hypotension. |
| Bortezomib | LOW | Both Haloperidol and Bortezomib can increase the risk of hypotension. |
| Brimonidine | LOW | Both Haloperidol and Brimonidine can increase the risk of hypotension. |
| Buclizine | LOW | Both Haloperidol and Buclizine have effects on the CNS and can cause sedation, which might affect... |
| Buprenorphine | LOW | Both Haloperidol and Buprenorphine have effects on the CNS and can cause sedation, which might af... |
| Canagliflozin | LOW | Both Haloperidol and Canagliflozin can increase the risk of hypotension. |
| Candesartan | LOW | Both Haloperidol and Candesartan can increase the risk of hypotension. |
| Cannabidiol | LOW | Both Haloperidol and Cannabidiol have effects on the CNS and can cause sedation, which might affe... |
| Captopril | LOW | Both Haloperidol and Captopril can increase the risk of hypotension. |
| Carboplatin | LOW | Both Haloperidol and Carboplatin can increase the risk of hyponatraemia. |
| Cariprazine | LOW | Both Haloperidol and Cariprazine can increase the risk of hyponatraemia. |
| Carvedilol | LOW | Both Haloperidol and Carvedilol can increase the risk of hypotension. |
| Celecoxib | LOW | Both Haloperidol and Celecoxib can increase the risk of hyponatraemia. |
| Celiprolol | LOW | Both Haloperidol and Celiprolol can increase the risk of hypotension. |
| Cenobamate | LOW | Both Haloperidol and Cenobamate have effects on the CNS and can cause sedation, which might affec... |
| Chloral hydrate | LOW | Both Haloperidol and Chloral hydrate have effects on the CNS and can cause sedation, which might ... |
| Chlordiazepoxide | LOW | Both Haloperidol and Chlordiazepoxide have effects on the CNS and can cause sedation, which might... |
| Chlorphenamine | LOW | Both Haloperidol and Chlorphenamine can cause antimuscarinic effects. |
| Cinnarizine | LOW | Both Haloperidol and Cinnarizine have effects on the CNS and can cause sedation, which might affe... |
| Cisplatin | LOW | Both Haloperidol and Cisplatin can increase the risk of hyponatraemia. |
| Clobazam | LOW | Both Haloperidol and Clobazam have effects on the CNS and can cause sedation, which might affect ... |
| Clomethiazole | LOW | Both Haloperidol and Clomethiazole have effects on the CNS and can cause sedation, which might af... |
| Clonazepam | LOW | Both Haloperidol and Clonazepam have effects on the CNS and can cause sedation, which might affec... |
| Clonidine | LOW | Both Haloperidol and Clonidine can increase the risk of hypotension. |
| Codeine | LOW | Both Haloperidol and Codeine have effects on the CNS and can cause sedation, which might affect t... |
| Cyclizine | LOW | Both Haloperidol and Cyclizine can cause antimuscarinic effects. |
| Cyclopentolate | LOW | Both Haloperidol and Cyclopentolate can cause antimuscarinic effects. |
| Cyclophosphamide | LOW | Both Haloperidol and Cyclophosphamide can increase the risk of hyponatraemia. |
| Cyproheptadine | LOW | Both Haloperidol and Cyproheptadine can cause antimuscarinic effects. |
| Dapagliflozin | LOW | Both Haloperidol and Dapagliflozin can increase the risk of hypotension. |
| Dapoxetine | LOW | Both Haloperidol and Dapoxetine have effects on the CNS and can cause sedation, which might affec... |
| Daridorexant | LOW | Both Haloperidol and Daridorexant have effects on the CNS and can cause sedation, which might aff... |
| Darifenacin | LOW | Both Haloperidol and Darifenacin can cause antimuscarinic effects. |
| Desmopressin | LOW | Both Haloperidol and Desmopressin can increase the risk of hyponatraemia. |
| Dexketoprofen | LOW | Both Haloperidol and Dexketoprofen can increase the risk of hyponatraemia. |
| Dexmedetomidine | LOW | Both Haloperidol and Dexmedetomidine have effects on the CNS and can cause sedation, which might ... |
| Diamorphine | LOW | Both Haloperidol and Diamorphine have effects on the CNS and can cause sedation, which might affe... |
| Diazepam | LOW | Both Haloperidol and Diazepam have effects on the CNS and can cause sedation, which might affect ... |
| Diazoxide | LOW | Both Haloperidol and Diazoxide can increase the risk of hypotension. |
| Diclofenac | LOW | Both Haloperidol and Diclofenac can increase the risk of hyponatraemia. |
| Dicycloverine | LOW | Both Haloperidol and Dicycloverine can cause antimuscarinic effects. |
| Difelikefalin | LOW | Both Haloperidol and Difelikefalin have effects on the CNS and can cause sedation, which might af... |
| Dihydrocodeine | LOW | Both Haloperidol and Dihydrocodeine have effects on the CNS and can cause sedation, which might a... |
| Diltiazem | LOW | Both Haloperidol and Diltiazem can increase the risk of hypotension. |
| Dimenhydrinate | LOW | Both Haloperidol and Dimenhydrinate can cause antimuscarinic effects. |
| Dipipanone | LOW | Both Haloperidol and Dipipanone have effects on the CNS and can cause sedation, which might affec... |
| Dipyridamole | LOW | Both Haloperidol and Dipyridamole can increase the risk of hypotension. |
| Dosulepin | LOW | Both Haloperidol and Dosulepin can increase the risk of hyponatraemia. |
| Doxazosin | LOW | Both Haloperidol and Doxazosin can increase the risk of hypotension. |
| Doxepin | LOW | Both Haloperidol and Doxepin can increase the risk of hyponatraemia. |
| Doxylamine | LOW | Both Haloperidol and Doxylamine have effects on the CNS and can cause sedation, which might affec... |
| Dronabinol | LOW | Both Haloperidol and Dronabinol have effects on the CNS and can cause sedation, which might affec... |
| Duloxetine | LOW | Both Haloperidol and Duloxetine can increase the risk of hyponatraemia. |
| Empagliflozin | LOW | Both Haloperidol and Empagliflozin can increase the risk of hypotension. |
| Enalapril | LOW | Both Haloperidol and Enalapril can increase the risk of hypotension. |
| Eplerenone | LOW | Both Haloperidol and Eplerenone can increase the risk of hypotension. |
| Epoprostenol | LOW | Both Haloperidol and Epoprostenol can increase the risk of hypotension. |
| Eprosartan | LOW | Both Haloperidol and Eprosartan can increase the risk of hypotension. |
| Ertugliflozin | LOW | Both Haloperidol and Ertugliflozin can increase the risk of hypotension. |
| Esketamine | LOW | Both Haloperidol and Esketamine can increase the risk of hypotension. |
| Eslicarbazepine | LOW | Both Haloperidol and Eslicarbazepine can increase the risk of hyponatraemia. |
| Esmolol | LOW | Both Haloperidol and Esmolol can increase the risk of hypotension. |
| Eszopiclone | LOW | Both Haloperidol and Eszopiclone have effects on the CNS and can cause sedation, which might affe... |
| Etodolac | LOW | Both Haloperidol and Etodolac can increase the risk of hyponatraemia. |
| Etomidate | LOW | Both Haloperidol and Etomidate can increase the risk of hypotension. |
| Etoricoxib | LOW | Both Haloperidol and Etoricoxib can increase the risk of hyponatraemia. |
| Felodipine | LOW | Both Haloperidol and Felodipine can increase the risk of hypotension. |
| Fentanyl | LOW | Both Haloperidol and Fentanyl have effects on the CNS and can cause sedation, which might affect ... |
| Fesoterodine | LOW | Both Haloperidol and Fesoterodine can cause antimuscarinic effects. |
| Finerenone | LOW | Both Haloperidol and Finerenone can increase the risk of hypotension. |
| Flavoxate | LOW | Both Haloperidol and Flavoxate can cause antimuscarinic effects. |
| Flupentixol | LOW | Both Haloperidol and Flupentixol can increase the risk of hyponatraemia. |
| Flurazepam | LOW | Both Haloperidol and Flurazepam have effects on the CNS and can cause sedation, which might affec... |
| Flurbiprofen | LOW | Both Haloperidol and Flurbiprofen can increase the risk of hyponatraemia. |
| Fosinopril | LOW | Both Haloperidol and Fosinopril can increase the risk of hypotension. |
| Gabapentin | LOW | Both Haloperidol and Gabapentin have effects on the CNS and can cause sedation, which might affec... |
| Glyceryl trinitrate | LOW | Both Haloperidol and Glyceryl trinitrate can increase the risk of hypotension. |
| Glycopyrronium | LOW | Both Haloperidol and Glycopyrronium can cause antimuscarinic effects. |
| Guanfacine | LOW | Both Haloperidol and Guanfacine can increase the risk of hypotension. |
| Homatropine | LOW | Both Haloperidol and Homatropine can cause antimuscarinic effects. |
| Hydralazine | LOW | Both Haloperidol and Hydralazine can increase the risk of hypotension. |
| Hydromorphone | LOW | Both Haloperidol and Hydromorphone have effects on the CNS and can cause sedation, which might af... |
| Hyoscine | LOW | Both Haloperidol and Hyoscine can cause antimuscarinic effects. |
| Ibuprofen | LOW | Both Haloperidol and Ibuprofen can increase the risk of hyponatraemia. |
| Iloprost | LOW | Both Haloperidol and Iloprost can increase the risk of hypotension. |
| Imidapril | LOW | Both Haloperidol and Imidapril can increase the risk of hypotension. |
| Imipramine | LOW | Both Haloperidol and Imipramine can increase the risk of hyponatraemia. |
| Indometacin | LOW | Both Haloperidol and Indometacin can increase the risk of hyponatraemia. |
| Indoramin | LOW | Both Haloperidol and Indoramin can increase the risk of hypotension. |
| Ipratropium | LOW | Both Haloperidol and Ipratropium can cause antimuscarinic effects. |
| Irbesartan | LOW | Both Haloperidol and Irbesartan can increase the risk of hypotension. |
| Isocarboxazid | LOW | Both Haloperidol and Isocarboxazid can increase the risk of hypotension. |
| Isosorbide dinitrate | LOW | Both Haloperidol and Isosorbide dinitrate can increase the risk of hypotension. |
| Isosorbide mononitrate | LOW | Both Haloperidol and Isosorbide mononitrate can increase the risk of hypotension. |
| Ketamine | LOW | Both Haloperidol and Ketamine can increase the risk of hypotension. |
| Ketoprofen | LOW | Both Haloperidol and Ketoprofen can increase the risk of hyponatraemia. |
| Ketorolac | LOW | Both Haloperidol and Ketorolac can increase the risk of hyponatraemia. |
| Ketotifen | LOW | Both Haloperidol and Ketotifen have effects on the CNS and can cause sedation, which might affect... |
| Labetalol | LOW | Both Haloperidol and Labetalol can increase the risk of hypotension. |
| Lacidipine | LOW | Both Haloperidol and Lacidipine can increase the risk of hypotension. |
| Lamotrigine | LOW | Both Haloperidol and Lamotrigine have effects on the CNS and can cause sedation, which might affe... |
| Landiolol | LOW | Both Haloperidol and Landiolol can increase the risk of hypotension. |
| Lercanidipine | LOW | Both Haloperidol and Lercanidipine can increase the risk of hypotension. |
| Levetiracetam | LOW | Both Haloperidol and Levetiracetam have effects on the CNS and can cause sedation, which might af... |
| Levobunolol | LOW | Both Haloperidol and Levobunolol can increase the risk of hypotension. |
| Lisinopril | LOW | Both Haloperidol and Lisinopril can increase the risk of hypotension. |
| Lofepramine | LOW | Both Haloperidol and Lofepramine can increase the risk of hyponatraemia. |
| Lofexidine | LOW | Both Haloperidol and Lofexidine can increase the risk of hypotension. |
| Loprazolam | LOW | Both Haloperidol and Loprazolam have effects on the CNS and can cause sedation, which might affec... |
| Lorazepam | LOW | Both Haloperidol and Lorazepam have effects on the CNS and can cause sedation, which might affect... |
| Lormetazepam | LOW | Both Haloperidol and Lormetazepam have effects on the CNS and can cause sedation, which might aff... |
| Losartan | LOW | Both Haloperidol and Losartan can increase the risk of hypotension. |
| Loxapine | LOW | Both Haloperidol and Loxapine can increase the risk of hyponatraemia. |
| Lurasidone | LOW | Both Haloperidol and Lurasidone can increase the risk of hyponatraemia. |
| Mannitol | LOW | Both Haloperidol and Mannitol can increase the risk of hyponatraemia. |
| Mefenamic acid | LOW | Both Haloperidol and Mefenamic acid can increase the risk of hyponatraemia. |
| Melatonin | LOW | Both Haloperidol and Melatonin have effects on the CNS and can cause sedation, which might affect... |
| Meloxicam | LOW | Both Haloperidol and Meloxicam can increase the risk of hyponatraemia. |
| Meptazinol | LOW | Both Haloperidol and Meptazinol have effects on the CNS and can cause sedation, which might affec... |
| Methocarbamol | LOW | Both Haloperidol and Methocarbamol have effects on the CNS and can cause sedation, which might af... |
| Methoxyflurane | LOW | Both Haloperidol and Methoxyflurane can increase the risk of hypotension. |
| Methyldopa | LOW | Both Haloperidol and Methyldopa can increase the risk of hypotension. |
| Metoprolol | LOW | Both Haloperidol and Metoprolol can increase the risk of hypotension. |
| Mianserin | LOW | Both Haloperidol and Mianserin have effects on the CNS and can cause sedation, which might affect... |
| Midazolam | LOW | Both Haloperidol and Midazolam have effects on the CNS and can cause sedation, which might affect... |
| Minoxidil | LOW | Both Haloperidol and Minoxidil can increase the risk of hypotension. |
| Mirtazapine | LOW | Both Haloperidol and Mirtazapine can increase the risk of hyponatraemia. |
| Morphine | LOW | Both Haloperidol and Morphine have effects on the CNS and can cause sedation, which might affect ... |
| Moxonidine | LOW | Both Haloperidol and Moxonidine can increase the risk of hypotension. |
| Nabilone | LOW | Both Haloperidol and Nabilone have effects on the CNS and can cause sedation, which might affect ... |
| Nabumetone | LOW | Both Haloperidol and Nabumetone can increase the risk of hyponatraemia. |
| Nadolol | LOW | Both Haloperidol and Nadolol can increase the risk of hypotension. |
| Naproxen | LOW | Both Haloperidol and Naproxen can increase the risk of hyponatraemia. |
| Nebivolol | LOW | Both Haloperidol and Nebivolol can increase the risk of hypotension. |
| Nicardipine | LOW | Both Haloperidol and Nicardipine can increase the risk of hypotension. |
| Nicorandil | LOW | Both Haloperidol and Nicorandil can increase the risk of hypotension. |
| Nifedipine | LOW | Both Haloperidol and Nifedipine can increase the risk of hypotension. |
| Nimodipine | LOW | Both Haloperidol and Nimodipine can increase the risk of hypotension. |
| Nitrazepam | LOW | Both Haloperidol and Nitrazepam have effects on the CNS and can cause sedation, which might affec... |
| Nitroprusside | LOW | Both Haloperidol and Nitroprusside can increase the risk of hypotension. |
| Nitrous oxide | LOW | Both Haloperidol and Nitrous oxide can increase the risk of hypotension. |
| Nortriptyline | LOW | Both Haloperidol and Nortriptyline can increase the risk of hyponatraemia. |
| Olanzapine | LOW | Both Haloperidol and Olanzapine can increase the risk of hyponatraemia. |
| Olmesartan | LOW | Both Haloperidol and Olmesartan can increase the risk of hypotension. |
| Orphenadrine | LOW | Both Haloperidol and Orphenadrine can cause antimuscarinic effects. |
| Oxazepam | LOW | Both Haloperidol and Oxazepam have effects on the CNS and can cause sedation, which might affect ... |
| Oxcarbazepine | LOW | Both Haloperidol and Oxcarbazepine can increase the risk of hyponatraemia. |
| Oxybutynin | LOW | Both Haloperidol and Oxybutynin can cause antimuscarinic effects. |
| Oxycodone | LOW | Both Haloperidol and Oxycodone have effects on the CNS and can cause sedation, which might affect... |
| Oxytocin | LOW | Both Haloperidol and Oxytocin can increase the risk of hyponatraemia. |
| Parecoxib | LOW | Both Haloperidol and Parecoxib can increase the risk of hyponatraemia. |
| Paroxetine | LOW | Both Haloperidol and Paroxetine can increase the risk of hyponatraemia. |
| Pentazocine | LOW | Both Haloperidol and Pentazocine have effects on the CNS and can cause sedation, which might affe... |
| Perampanel | LOW | Both Haloperidol and Perampanel have effects on the CNS and can cause sedation, which might affec... |
| Pericyazine | LOW | Both Haloperidol and Pericyazine can increase the risk of hyponatraemia. |
| Perindopril | LOW | Both Haloperidol and Perindopril can increase the risk of hypotension. |
| Pethidine | LOW | Both Haloperidol and Pethidine have effects on the CNS and can cause sedation, which might affect... |
| Phenazone | LOW | Both Haloperidol and Phenazone can increase the risk of hyponatraemia. |
| Phenelzine | LOW | Both Haloperidol and Phenelzine can increase the risk of hypotension. |
| Pindolol | LOW | Both Haloperidol and Pindolol can increase the risk of hypotension. |
| Piroxicam | LOW | Both Haloperidol and Piroxicam can increase the risk of hyponatraemia. |
| Pizotifen | LOW | Both Haloperidol and Pizotifen have effects on the CNS and can cause sedation, which might affect... |
| Prazosin | LOW | Both Haloperidol and Prazosin can increase the risk of hypotension. |
| Pregabalin | LOW | Both Haloperidol and Pregabalin have effects on the CNS and can cause sedation, which might affec... |
| Pridinol | LOW | Both Haloperidol and Pridinol can cause antimuscarinic effects. |
| Prochlorperazine | LOW | Both Haloperidol and Prochlorperazine can increase the risk of hyponatraemia. |
| Procyclidine | LOW | Both Haloperidol and Procyclidine can cause antimuscarinic effects. |
| Promazine | LOW | Both Haloperidol and Promazine can increase the risk of hyponatraemia. |
| Propafenone | LOW | Both Haloperidol and Propafenone can cause antimuscarinic effects. |
| Propantheline | LOW | Both Haloperidol and Propantheline can cause antimuscarinic effects. |
| Propiverine | LOW | Both Haloperidol and Propiverine can cause antimuscarinic effects. |
| Propofol | LOW | Both Haloperidol and Propofol can increase the risk of hypotension. |
| Propranolol | LOW | Both Haloperidol and Propranolol can increase the risk of hypotension. |
| Quetiapine | LOW | Both Haloperidol and Quetiapine can increase the risk of hyponatraemia. |
| Quinapril | LOW | Both Haloperidol and Quinapril can increase the risk of hypotension. |
| Ramipril | LOW | Both Haloperidol and Ramipril can increase the risk of hypotension. |
| Remifentanil | LOW | Both Haloperidol and Remifentanil have effects on the CNS and can cause sedation, which might aff... |
| Remimazolam | LOW | Both Haloperidol and Remimazolam have effects on the CNS and can cause sedation, which might affe... |
| Riociguat | LOW | Both Haloperidol and Riociguat can increase the risk of hypotension. |
| Risperidone | LOW | Both Haloperidol and Risperidone can increase the risk of hyponatraemia. |
| Rufinamide | LOW | Both Haloperidol and Rufinamide have effects on the CNS and can cause sedation, which might affec... |
| Sacubitril | LOW | Both Haloperidol and Sacubitril can increase the risk of hypotension. |
| Sapropterin | LOW | Both Haloperidol and Sapropterin can increase the risk of hypotension. |
| Selegiline | LOW | Both Haloperidol and Selegiline can increase the risk of hypotension. |
| Sertraline | LOW | Both Haloperidol and Sertraline can increase the risk of hyponatraemia. |
| Sildenafil | LOW | Both Haloperidol and Sildenafil can increase the risk of hypotension. |
| Sodium oxybate | LOW | Both Haloperidol and Sodium oxybate can increase the risk of hypotension. |
| Solifenacin | LOW | Both Haloperidol and Solifenacin can cause antimuscarinic effects. |
| Sparsentan | LOW | Both Haloperidol and Sparsentan can increase the risk of hypotension. |
| Spironolactone | LOW | Both Haloperidol and Spironolactone can increase the risk of hypotension. |
| Sufentanil | LOW | Both Haloperidol and Sufentanil have effects on the CNS and can cause sedation, which might affec... |
| Sulindac | LOW | Both Haloperidol and Sulindac can increase the risk of hyponatraemia. |
| Sulpiride | LOW | Both Haloperidol and Sulpiride can increase the risk of hyponatraemia. |
| Tadalafil | LOW | Both Haloperidol and Tadalafil can increase the risk of hypotension. |
| Tamsulosin | LOW | Both Haloperidol and Tamsulosin can increase the risk of hypotension. |
| Tapentadol | LOW | Both Haloperidol and Tapentadol have effects on the CNS and can cause sedation, which might affec... |
| Telmisartan | LOW | Both Haloperidol and Telmisartan can increase the risk of hypotension. |
| Temazepam | LOW | Both Haloperidol and Temazepam have effects on the CNS and can cause sedation, which might affect... |
| Tenoxicam | LOW | Both Haloperidol and Tenoxicam can increase the risk of hyponatraemia. |
| Terazosin | LOW | Both Haloperidol and Terazosin can increase the risk of hypotension. |
| Thalidomide | LOW | Both Haloperidol and Thalidomide have effects on the CNS and can cause sedation, which might affe... |
| Thiopental | LOW | Both Haloperidol and Thiopental can increase the risk of hypotension. |
| Tiaprofenic acid | LOW | Both Haloperidol and Tiaprofenic acid can increase the risk of hyponatraemia. |
| Timolol | LOW | Both Haloperidol and Timolol can increase the risk of hypotension. |
| Tiotropium | LOW | Both Haloperidol and Tiotropium can cause antimuscarinic effects. |
| Tizanidine | LOW | Both Haloperidol and Tizanidine can increase the risk of hypotension. |
| Tolfenamic acid | LOW | Both Haloperidol and Tolfenamic acid can increase the risk of hyponatraemia. |
| Tramadol | LOW | Both Haloperidol and Tramadol can increase the risk of hyponatraemia. |
| Trandolapril | LOW | Both Haloperidol and Trandolapril can increase the risk of hypotension. |
| Tranylcypromine | LOW | Both Haloperidol and Tranylcypromine can increase the risk of hypotension. |
| Trazodone | LOW | Both Haloperidol and Trazodone can increase the risk of hyponatraemia. |
| Treprostinil | LOW | Both Haloperidol and Treprostinil can increase the risk of hypotension. |
| Trifluoperazine | LOW | Both Haloperidol and Trifluoperazine can increase the risk of hyponatraemia. |
| Trihexyphenidyl | LOW | Both Haloperidol and Trihexyphenidyl can cause antimuscarinic effects. |
| Trimipramine | LOW | Both Haloperidol and Trimipramine can increase the risk of hyponatraemia. |
| Tropicamide | LOW | Both Haloperidol and Tropicamide can cause antimuscarinic effects. |
| Trospium | LOW | Both Haloperidol and Trospium can cause antimuscarinic effects. |
| Umeclidinium | LOW | Both Haloperidol and Umeclidinium can cause antimuscarinic effects. |
| Valproate | LOW | Both Haloperidol and Valproate can increase the risk of hyponatraemia. |
| Valsartan | LOW | Both Haloperidol and Valsartan can increase the risk of hypotension. |
| Verapamil | LOW | Both Haloperidol and Verapamil can increase the risk of hypotension. |
| Vericiguat | LOW | Both Haloperidol and Vericiguat can increase the risk of hypotension. |
| Vigabatrin | LOW | Both Haloperidol and Vigabatrin have effects on the CNS and can cause sedation, which might affec... |
| Vinblastine | LOW | Both Haloperidol and Vinblastine can increase the risk of hyponatraemia. |
| Vincristine | LOW | Both Haloperidol and Vincristine can increase the risk of hyponatraemia. |
| Vinorelbine | LOW | Both Haloperidol and Vinorelbine can increase the risk of hyponatraemia. |
| Zolpidem | LOW | Both Haloperidol and Zolpidem have effects on the CNS and can cause sedation, which might affect ... |
| Zopiclone | LOW | Both Haloperidol and Zopiclone have effects on the CNS and can cause sedation, which might affect... |
| Zuclopenthixol | LOW | Both Haloperidol and Zuclopenthixol can increase the risk of hyponatraemia. |
Check Haloperidol against your patient's full medication list
InteractRx checks all drug combinations at once — built for GP surgery pharmacists.
Use the Free Checker